Lifeline Endocardial Pacing Lead
by Intermedics, Inc. 510(k)
Active
510(k) K792168
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK792168 | Date13 Nov 1979 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Lifeline Endocardial Pacing Lead is a Permanent Pacemaker Electrode (product code DTB), designed to deliver electrical stimulation directly to the heart muscle. It is intended for use in cardiac pacing systems to regulate heart rate in patients with bradycardia or conduction disorders.
This device is supplied sterile and intended for single-use implantation within the endocardium. It is classified as a Class III medical device under FDA regulations (870.3680) and was granted FDA 510(k) clearance (K792168) in 1979. Compatible with MRI environments as per manufacturer specifications, it is distributed in sterile packaging for surgical use.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the Lifeline Endocardial Pacing Lead primarily used for in clinical practice?
The Lifeline Endocardial Pacing Lead is designed to deliver electrical stimulation directly to the heart muscle as part of a cardiac pacing system. It is intended for patients with bradycardia (slow heart rate) or conduction disorders, helping to regulate their heart rhythm by ensuring consistent electrical impulses.
Is the Lifeline Endocardial Pacing Lead intended for reuse, or is it meant to be implanted once and discarded?
The device is supplied sterile and explicitly intended for single-use implantation within the endocardium. Once implanted, it is not designed for removal or reuse, adhering to standard sterile surgical practices for permanent pacemaker electrodes.
How is the Lifeline Endocardial Pacing Lead packaged for surgical use, and what does that imply for handling?
The lead is distributed in sterile packaging, ensuring it remains uncontaminated until ready for implantation. This packaging is designed for surgical environments, meaning it must be opened aseptically under sterile conditions to maintain sterility before use.
Can this device be used in patients who require MRI scans, and what considerations should be made?
Yes, the Lifeline Endocardial Pacing Lead is compatible with MRI environments according to the manufacturer’s specifications. However, MRI use must follow strict protocols to avoid interference or complications, such as adhering to MRI-safe positioning and field strength guidelines to ensure patient safety.
What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its classification?
The Lifeline Endocardial Pacing Lead underwent a Traditional 510(k) review through the FDA’s Cardiovascular (CV) advisory committee, with a decision of Substantially Equivalent (SE) to a predicate device. It is classified as a Class III medical device (870.3680), reflecting its role in life-sustaining or supporting functions, which requires rigorous pre-market clearance.